Practice
Featured experience
Bristol Myers Squibb $13 billion notes offering
The investment-grade offering comprised nine tranches
Cisco Systems $13.5 billion notes offering
The investment-grade offering comprises seven tranches of notes
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Novartis $3.7 billion notes offering
We advised Novartis on the investment-grade debt offering
Cleveland-Cliffs $825 million notes offering and concurrent tender offer
The high-yield notes are due 2032
Clear Channel Outdoor Holdings $865 million senior secured notes offering
The 7.875% notes are due 2030
GPA R$704 million equity offering
The common shares are listed on the São Paulo Stock Exchange
BBVA $2 billion senior notes offering
We advised BBVA on its offering of senior preferred fixed-rate notes and senior non-preferred fixed-to-fixed-rate notes
Banco Santander $4 billion notes offering
We advised Banco Santander on the notes due 2028, 2030 and 2034
Nayax $94 million follow-on offering
We advised Nayax on the offering of shares
MediaAlpha $59.6 million secondary offering
The stock is listed on the New York Stock Exchange
PAR Technology $200 million private placement
Proceeds from the offering will be used to partially fund the company’s acquisition of Stuzo Holdings
Avid Bioservices $160 million convertible senior notes offering
The convertible notes are due 2029
REGENXBIO $140 million stock and pre-funded warrants offering
The stock is listed on the Nasdaq Global Select Market